ACCELERATE DIAGNOSTICS, INC : Other Events (form 8-K)

Published: 2021-10-18 06:08:07 ET AXDX

On October 15, 2021, Accelerate Diagnostics, Inc. (the "Company") closed its previously announced privately negotiated exchange with a holder of its 2.50% Convertible Senior Notes due 2023 (the "Notes"). In connection with the closing, the holder exchanged approximately $5 million in aggregate principal amount of Notes, and the Company issued an aggregate of 657,256 shares of its common stock to such holder.

The closing completes the exchange transactions (the "Exchange Transactions") pursuant to the exchange agreements entered into by the Company and certain holders of the Notes on September 22, 2021. For additional information regarding the Exchange Transactions and the related exchange agreements, see the Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission on September 23, 2021 and October 1, 2021. Following the completion of the Exchange Transactions, $120.5 million aggregate principal amount of the Notes remain outstanding.